A combination of p-tau217 levels and Aβ42/40 ratio measured in antemortem plasma strongly predicts AD amyloid and tau load in postmortem analysis with an AUC = 0.89 [0.82–0.96], but not significantly better than p-tau217 alone (p = 0.124) [171]. This evidence concerns the gene MAPT and Alzheimer disease.